Related Experiment Video

Updated: Aug 19, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
11:17

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays

Published on: January 7, 2016

Growth hormone deficiency in children: an approach to a child with short stature

Subhankar Chowdhury1, Purushottam Chatterjee

  • 1Department of Endocrinology, IPGME&R and SSKM Hospital, Kolkata 700020.

Journal of the Indian Medical Association
|February 22, 2005
PubMed

Insights

Recognizing short stature in children is crucial for diagnosing underlying medical conditions. Early identification and treatment, such as growth hormone therapy for growth hormone deficiency, can significantly improve growth outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Short stature in children can indicate various underlying medical conditions, necessitating prompt recognition.
  • A wide range of factors contribute to short stature, including familial, idiopathic, and chronic illnesses.

Purpose of the Study:

  • To highlight the significance of identifying short stature in pediatric patients.
  • To outline the diagnostic approach and management of growth hormone deficiency.

Main Methods:

  • Comprehensive patient history and physical examination.
  • Endocrine and non-endocrine investigations to determine the cause of short stature.
  • Growth hormone stimulation tests to diagnose growth hormone deficiency.

Main Results:

  • Growth hormone deficiency is a key factor affecting physical growth in children.
  • A peak growth hormone level below 10 microg/l, coupled with clinical signs, aids in diagnosing growth hormone deficiency.

Conclusions:

  • Accurate diagnosis of short stature requires thorough evaluation, including specialized tests.
  • Subcutaneous administration of growth hormone (25-50 microg/kg/day) at bedtime is the recommended treatment for growth hormone deficiency.

More Related Videos

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...